ResApp share price races 13% higher on telehealth deal

The ResApp Health Ltd (ASX:RAP) share price is racing higher on Thursday following the announcement of a promising deal with Coviu…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In morning trade the ResApp Health Ltd (ASX: RAP) share price is storming higher.

At the time of writing the digital health company's shares are up 13% to 30.5 cents.

Why is the ResApp share price racing higher?

Investors have been buying ResApp's shares following an update on its ResAppDx-EU product.

ResAppDx-EU is a software application used by clinicians to diagnose the most common respiratory diseases. This software uses machine learning algorithms to analyse a patient's cough sounds and diagnose diseases.

According to today's update, ResApp and Australia's leading telehealth software platform, Coviu, have entered into a non-binding memorandum of understanding (MOU) to integrate ResAppDx-EU into Coviu's browser-based telehealth platform.

This integration will see ResAppDx-EU become available to over 5,500 clinicians who currently use the Coviu platform. Clinicians will then have the ability to accurately diagnose respiratory disease in a telehealth setting.

The Coviu telehealth platform, a spinout from CSIRO's Data61, makes it easy for healthcare providers to offer their services directly to patients via video consultation. It also powers the Australian government-funded healthdirect Video Call.

ResApp's CEO and Managing Director, Tony Keating, was very excited with the MOU.

He said: "We are excited to be working with Coviu, which has developed a technologically-advanced telehealth platform with one of the largest active deployments in Australia. This is a great opportunity to integrate ResApp's solution into a leading telehealth provider's platform and demonstrate the value we deliver in the telehealth setting."

This sentiment was echoed by Coviu's CEO, Dr Silvia Pfeiffer.

Dr Pfeiffer said: "At Coviu we are committed to providing the best software for video visits so that doctors can bring the same level of outstanding care that they provide in face-to-face consultations to online consultations. We look forward to being able to provide ResApp's respiratory diagnostic solutions as a tool for clinicians who use our platform to accurately diagnose and care for patients with respiratory conditions."

What's next?

The two parties will work together under a joint development agreement for the next four months to integrate ResAppDx-EU into Coviu's browser-based telehealth platform.

They will also devise a workflow for directing patients and clinicians towards the use of ResAppDx-EU in appropriate circumstances and prepare a list of actions for clinicians to take after reviewing the test results.

Before the conclusion of the project, ResApp and Coviu will enter into negotiations on the cost model of using ResAppDx-EU on the Coviu platform within Australia.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

A businessman stacks building blocks.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares hit a new record high today.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher

These shares are having a better day than most on Thursday. But why?

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors endured a day to forget this hump day.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Droneshield, Meteoric Resources, Mount Gibson, and Tyro shares are charging higher

These shares are having a good time on hump day. But why?

Read more »